121 related articles for article (PubMed ID: 37747775)
41. Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122.
Su R; Cao S; Ma J; Liu Y; Liu X; Zheng J; Chen J; Liu L; Cai H; Li Z; Zhao L; He Q; Xue Y
Mol Cancer; 2017 Nov; 16(1):171. PubMed ID: 29132362
[TBL] [Abstract][Full Text] [Related]
42. Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance.
Shi Y; Guryanova OA; Zhou W; Liu C; Huang Z; Fang X; Wang X; Chen C; Wu Q; He Z; Wang W; Zhang W; Jiang T; Liu Q; Chen Y; Wang W; Wu J; Kim L; Gimple RC; Feng H; Kung HF; Yu JS; Rich JN; Ping YF; Bian XW; Bao S
Sci Transl Med; 2018 May; 10(443):. PubMed ID: 29848664
[TBL] [Abstract][Full Text] [Related]
43. EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma.
Fan QW; Cheng CK; Gustafson WC; Charron E; Zipper P; Wong RA; Chen J; Lau J; Knobbe-Thomsen C; Weller M; Jura N; Reifenberger G; Shokat KM; Weiss WA
Cancer Cell; 2013 Oct; 24(4):438-49. PubMed ID: 24135280
[TBL] [Abstract][Full Text] [Related]
44. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
[TBL] [Abstract][Full Text] [Related]
45. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
[TBL] [Abstract][Full Text] [Related]
46. IGFBP2 potentiates nuclear EGFR-STAT3 signaling.
Chua CY; Liu Y; Granberg KJ; Hu L; Haapasalo H; Annala MJ; Cogdell DE; Verploegen M; Moore LM; Fuller GN; Nykter M; Cavenee WK; Zhang W
Oncogene; 2016 Feb; 35(6):738-47. PubMed ID: 25893308
[TBL] [Abstract][Full Text] [Related]
47. The effects of type I interferon on glioblastoma cancer stem cells.
Du Z; Cai C; Sims M; Boop FA; Davidoff AM; Pfeffer LM
Biochem Biophys Res Commun; 2017 Sep; 491(2):343-348. PubMed ID: 28728846
[TBL] [Abstract][Full Text] [Related]
48. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C
Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687
[TBL] [Abstract][Full Text] [Related]
50. E3 ubiquitin-ligase RNF138 may regulate p53 protein expression to regulate the self-renewal and tumorigenicity of glioma stem cells.
Chao Q; Li X; Huang Y
J Cancer Res Ther; 2023 Dec; 19(6):1636-1645. PubMed ID: 38156932
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol.
Ren Y; Zhou X; Mei M; Yuan XB; Han L; Wang GX; Jia ZF; Xu P; Pu PY; Kang CS
BMC Cancer; 2010 Jan; 10():27. PubMed ID: 20113523
[TBL] [Abstract][Full Text] [Related]
52. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
[TBL] [Abstract][Full Text] [Related]
53. Methylation by EZH2 activates STAT3 in glioblastoma.
Cancer Discov; 2013 Jul; 3(7):OF21. PubMed ID: 23847365
[TBL] [Abstract][Full Text] [Related]
54. miR-30 overexpression promotes glioma stem cells by regulating Jak/STAT3 signaling pathway.
Che S; Sun T; Wang J; Jiao Y; Wang C; Meng Q; Qi W; Yan Z
Tumour Biol; 2015 Sep; 36(9):6805-11. PubMed ID: 25840690
[TBL] [Abstract][Full Text] [Related]
55. Control of glioblastoma tumorigenesis by feed-forward cytokine signaling.
Jahani-Asl A; Yin H; Soleimani VD; Haque T; Luchman HA; Chang NC; Sincennes MC; Puram SV; Scott AM; Lorimer IA; Perkins TJ; Ligon KL; Weiss S; Rudnicki MA; Bonni A
Nat Neurosci; 2016 Jun; 19(6):798-806. PubMed ID: 27110918
[TBL] [Abstract][Full Text] [Related]
56. An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential
Mokgautsi N; Wen YT; Lawal B; Khedkar H; Sumitra MR; Wu ATH; Huang HS
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671112
[TBL] [Abstract][Full Text] [Related]
57. STEAP3 promotes cancer cell proliferation by facilitating nuclear trafficking of EGFR to enhance RAC1-ERK-STAT3 signaling in hepatocellular carcinoma.
Wang LL; Luo J; He ZH; Liu YQ; Li HG; Xie D; Cai MY
Cell Death Dis; 2021 Nov; 12(11):1052. PubMed ID: 34741044
[TBL] [Abstract][Full Text] [Related]
58. Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cells.
Wang X; Yang K; Wu Q; Kim LJY; Morton AR; Gimple RC; Prager BC; Shi Y; Zhou W; Bhargava S; Zhu Z; Jiang L; Tao W; Qiu Z; Zhao L; Zhang G; Li X; Agnihotri S; Mischel PS; Mack SC; Bao S; Rich JN
Sci Transl Med; 2019 Aug; 11(504):. PubMed ID: 31391321
[TBL] [Abstract][Full Text] [Related]
59. NFAT1-Mediated Regulation of NDEL1 Promotes Growth and Invasion of Glioma Stem-like Cells.
Jiang Y; Song Y; Wang R; Hu T; Zhang D; Wang Z; Tie X; Wang M; Han S
Cancer Res; 2019 May; 79(10):2593-2603. PubMed ID: 30940662
[TBL] [Abstract][Full Text] [Related]
60. PARK7 maintains the stemness of glioblastoma stem cells by stabilizing epidermal growth factor receptor variant III.
Kim JY; Kim HJ; Jung CW; Choi BI; Lee DH; Park MJ
Oncogene; 2021 Jan; 40(3):508-521. PubMed ID: 33188296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]